Activist Investor Laser Shines On Latest Pharma Target
This article was originally published in Scrip
Executive Summary
We don't wish to speculate on the personal reasons that prompted Bavarian Nordic A/S's executive vice president and chief development officer Dr Jim Breitmeyer to resign on Aug. 5, two days after famed short seller Sahm Adrangi's hedge fund Kerrisdale Capital turned its laser on the Danish firm. Suffice to say, his resignation releases him from what promises to be an unpleasant and drawn-out short-selling campaign.